- Home
- ONB vs MDGL Comparison
ONB vs MDGL Comparison
Compare ONB & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONB
- MDGL
- Stock Information
- Founded
- ONB 1834
- MDGL 2011
- Country
- ONB United States
- MDGL United States
- Employees
- ONB N/A
- MDGL N/A
- Industry
- ONB Major Banks
- MDGL Biotechnology: Pharmaceutical Preparations
- Sector
- ONB Finance
- MDGL Health Care
- Exchange
- ONB Nasdaq
- MDGL Nasdaq
- Market Cap
- ONB 6.0B
- MDGL 6.0B
- IPO Year
- ONB N/A
- MDGL N/A
- Fundamental
- Price
- ONB $19.68
- MDGL $210.47
- Analyst Decision
- ONB Buy
- MDGL Buy
- Analyst Count
- ONB 7
- MDGL 14
- Target Price
- ONB $19.86
- MDGL $343.83
- AVG Volume (30 Days)
- ONB 1.7M
- MDGL 287.0K
- Earning Date
- ONB 10-22-2024
- MDGL 11-04-2024
- Dividend Yield
- ONB 2.85%
- MDGL N/A
- EPS Growth
- ONB N/A
- MDGL N/A
- EPS
- ONB 1.70
- MDGL N/A
- Revenue
- ONB $1,729,090,000.00
- MDGL $14,638,000.00
- Revenue This Year
- ONB N/A
- MDGL N/A
- Revenue Next Year
- ONB $5.76
- MDGL $269.77
- P/E Ratio
- ONB $11.60
- MDGL N/A
- Revenue Growth
- ONB N/A
- MDGL N/A
- 52 Week Low
- ONB $12.36
- MDGL $119.76
- 52 Week High
- ONB $20.43
- MDGL $299.98
- Technical
- Relative Strength Index (RSI)
- ONB 66.37
- MDGL 37.55
- Support Level
- ONB $17.99
- MDGL $204.67
- Resistance Level
- ONB $18.43
- MDGL $218.55
- Average True Range (ATR)
- ONB 0.40
- MDGL 7.06
- MACD
- ONB 0.17
- MDGL 1.41
- Stochastic Oscillator
- ONB 96.50
- MDGL 35.23
About ONB Old National Bancorp
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.